Synthetic epidermicin NI01 can protect Galleria mellonella larvae from infection with Staphylococcus aureus
Author(s) -
Tarek M. Gibreel,
Mathew Upton
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt195
Subject(s) - galleria mellonella , microbiology and biotechnology , staphylococcus aureus , vancomycin , antimicrobial , in vivo , antibiotics , biology , antimicrobial peptides , immune system , potency , in vitro , bacteria , immunology , virulence , biochemistry , genetics , gene
Epidermicin is a novel antimicrobial peptide that has potent activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, and it may have potential for use in therapy for infections caused by these bacteria, though in vivo efficacy needs to be demonstrated. Galleria mellonella larvae have recently been introduced as an alternative in vivo model to mammalian systems and here we examined the ability of a synthetic version of epidermicin to protect G. mellonella larvae from infection with S. aureus strains.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom